DJIA 17,814.94 -2.96 -0.02%
NASDAQ 4,758.25 3.36 0.07%
S&P 500 2,067.03 -2.38 -0.12%
market minute promo

ImmunoGen (NASDAQ: IMGN)

9.84 -0.25 (-2.48%)

REAL-TIME: Last trade at

company name or ticker

Recent Quotes

IMGN $9.84 -2.48%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $10.09
Previous Close $10.09
Daily Range $9.79 - $10.15
52-Week Range $7.70 - $17.80
Market Cap $845.6M
P/E Ratio -10.51
Dividend (Yield) $0.00 (0.0%)
Volume 776,949
Average Daily Volume 1,653,990
Current FY EPS -$0.71





ImmunoGen (IMGN) Description

ImmunoGen develops cancer therapeutics through its tumor-activated, prodrug technology, which targets antibodies with cancer-killing drugs. Website:

News & Commentary Rss Feed

Why ImmunoGen, Inc. Stock Plunged 13% in October

ImmunoGen is among biotech's worst stocks in October after the company reports weaker-than-expected third quarter results. Find out if a rebound is in the cards.

ImmunoGen: Analysis Of Earnings Miss

ImmunoGen, Inc. Pushes Forward

With just $4.2 million in royalties from Roche's Kadcyla, investors need to be focused on ImmunoGen's internal pipeline.

ImmunoGen's (IMGN) CEO Daniel Junius on Q1 2015 Results - Earnings Call Transcript

ImmunoGen (IMGN) Q3 2014 Results - Earnings Call Webcast

ImmunoGen (IMGN) in Focus: Stock Rallies 14% - Tale of the Tape

ImmunoGen (IMGN) in Focus: Stock Rallies 14% - Tale of the Tape

Immunogen (IMGN) Highlighted As Today's Perilous Reversal Stock

Trade-Ideas: Immunogen (IMGN) Is Today's Strong On High Relative Volume Stock

Today's Weak On High Volume Stock: Immunogen (IMGN)

3 Value Stocks Near 52-Week Lows Worth Buying

These value stocks may be hitting a new 52-week low, but they may not be there for long!

See More IMGN News...

IMGN's Top Competitors

IMGN $9.84 (-2.48%)
Current stock: IMGN
AMGN $162.24 (-1.18%)
Current stock: AMGN
GILD $101.11 (0.51%)
Current stock: GILD
BIIB $305.40 (-0.44%)
Current stock: BIIB